Idiopathic pyoderma gangrenosum: successful resolution with infliximab therapy and pro-inflammatory cytokines assessment

Acta Derm Venereol. 2012 Jul;92(4):439-40. doi: 10.2340/00015555-1301.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antitubercular Agents / therapeutic use
  • Biopsy
  • Cytokines / blood*
  • Dermatologic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Glucocorticoids / therapeutic use
  • Humans
  • Inflammation Mediators / blood*
  • Infliximab
  • Latent Tuberculosis / diagnosis
  • Latent Tuberculosis / drug therapy
  • Male
  • Middle Aged
  • Prednisone / therapeutic use
  • Pyoderma Gangrenosum / blood
  • Pyoderma Gangrenosum / diagnosis
  • Pyoderma Gangrenosum / drug therapy*
  • Pyoderma Gangrenosum / immunology
  • Skin / drug effects*
  • Skin / pathology
  • Treatment Outcome
  • Wound Healing / drug effects

Substances

  • Antibodies, Monoclonal
  • Antitubercular Agents
  • Cytokines
  • Dermatologic Agents
  • Glucocorticoids
  • Inflammation Mediators
  • Infliximab
  • Prednisone